" class="no-js "lang="en-US"> Equipment Archives - Page 2 of 10 - Medtech Alert
Sunday, October 01, 2023

Sort by:


Top Post

Roche Launches a Digital PCR System, a Powerful New Diagnostics Platform in the Fight Against Cancer and Other Diseases

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Digital LightCyclerⓇ System, Roche’s first […]

Roche Launches COVID-19 Test That Detects and Differentiates the Emerging Variant of Interest BA.2.75

Roche (SIX: RO, ROG;OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed a  COVID-19 test for […]

NHS Trials Smart Goggles to Give Nurses More Time With Patients

High tech goggles will be worn by community nurses on home visits to free up […]

Karkinos Healthcare Engages OptraSCAN® Digital Pathology In its Mission of Personalized Cancer Care

OptraSCAN®, a leading end-to-end digital pathology solution provider, today announced that Karkinos Healthcare has begun using the […]

GITAI Develops Inchworm-Type Robotic Arm Extending Both the Capability and Mobility of Space Robots and Completes Proof-of-Concept Demonstration (TRL 3)

GITAI USA Inc. (GITAI), the world’s leading space robotics company, developed the GITAI IN1 (Inchworm One), a […]

CHMP Recommends EU Approval of Roche’s Vabysmo, the First Bispecific Antibody for the Eye, for Two Leading Causes of Vision Loss

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s (EMA) Committee […]

MD Anderson and Obsidian Therapeutics Announce FDA Clearance of IND Application for Novel TIL Therapy Obx-115

The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced Food and Drug Administration (FDA) clearance […]

KromaTiD Launches dGH™ Cell Prep Kit

KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more